Literature DB >> 9007079

Sindbis virus infection of neonatal mice results in a severe stress response.

J Trgovcich1, K Ryman, P Extrom, J C Eldridge, J F Aronson, R E Johnston.   

Abstract

Neonatal mice were infected with virus derived from a molecular clone of a laboratory strain of Sindbis virus, TRSB. The resulting acute fatal infection was typified by few if any of the classic hallmarks of encephalitis, very high levels of interferon-alpha/beta (IFNalphabeta), and lesions in the thymus and hematopoietic tissues usually associated with a severe stress response. Infection with an attenuated mutant of TRSB, which harbors a single amino acid change in the E2 surface glycoprotein (TRSBr114), was characterized by encephalitis, reduced mortality, low levels of IFNalphabeta, and no thymic pathology (J. Trgovcich, J. F. Aronson, and R. E. Johnston, 1996, Virology 224, 73-83). Here we report that infection of neonatal mice with TRSB, but not TRSBr114, resulted in induction of high levels of tumor necrosis factor-alpha as well as high and sustained levels of adrenalcorticotropin-releasing hormone and corticosterone. This syndrome of potentially toxic cytokine and stress hormone induction correlates with lethal Sindbis virus infection and constitutes a previously unrecognized aspect of Sindbis virus pathogenesis in mice.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9007079     DOI: 10.1006/viro.1996.8289

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  11 in total

1.  New PARP gene with an anti-alphavirus function.

Authors:  Svetlana Atasheva; Maryna Akhrymuk; Elena I Frolova; Ilya Frolov
Journal:  J Virol       Date:  2012-05-23       Impact factor: 5.103

2.  Early events in alphavirus replication determine the outcome of infection.

Authors:  Ilya Frolov; Maryna Akhrymuk; Ivan Akhrymuk; Svetlana Atasheva; Elena I Frolova
Journal:  J Virol       Date:  2012-02-15       Impact factor: 5.103

3.  Replication and clearance of Venezuelan equine encephalitis virus from the brains of animals vaccinated with chimeric SIN/VEE viruses.

Authors:  Slobodan Paessler; Haolin Ni; Olga Petrakova; Rafik Z Fayzulin; Nadezhda Yun; Michael Anishchenko; Scott C Weaver; Ilya Frolov
Journal:  J Virol       Date:  2006-03       Impact factor: 5.103

4.  Identification of adult mouse neurovirulence determinants of the Sindbis virus strain AR86.

Authors:  Mehul S Suthar; Reed Shabman; Kenya Madric; Cassandra Lambeth; Mark T Heise
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

5.  Roles of nonstructural protein nsP2 and Alpha/Beta interferons in determining the outcome of Sindbis virus infection.

Authors:  Elena I Frolova; Rafik Z Fayzulin; Susan H Cook; Diane E Griffin; Charles M Rice; Ilya Frolov
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

6.  Infection of neonatal mice with sindbis virus results in a systemic inflammatory response syndrome.

Authors:  W B Klimstra; K D Ryman; K A Bernard; K B Nguyen; C A Biron; R E Johnston
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

7.  Differences in cytokine and chemokine responses during neurological disease induced by polytropic murine retroviruses Map to separate regions of the viral envelope gene.

Authors:  K E Peterson; S J Robertson; J L Portis; B Chesebro
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

8.  Apoptosis in the mouse central nervous system in response to infection with mouse-neurovirulent dengue viruses.

Authors:  P Desprès; M P Frenkiel; P E Ceccaldi; C Duarte Dos Santos; V Deubel
Journal:  J Virol       Date:  1998-01       Impact factor: 5.103

9.  Sindbis virus induces apoptosis through a caspase-dependent, CrmA-sensitive pathway.

Authors:  V E Nava; A Rosen; M A Veliuona; R J Clem; B Levine; J M Hardwick
Journal:  J Virol       Date:  1998-01       Impact factor: 5.103

10.  Resistance of interleukin-1beta-deficient mice to fatal Sindbis virus encephalitis.

Authors:  X H Liang; J E Goldman; H H Jiang; B Levine
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.